Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H36N6O4 |
InChIKeyFZEPAZRIEAMJFE-UHFFFAOYSA-N |
CAS Registry2368182-63-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 22 Feb 2021 |





